Long-term efficacy of subantimicrobial-dose doxycycline as an adjunctive treatment to scaling and root planing: A systematic review and meta-analysis

Journal of Periodontology

Volumn 82, Issue 11, 2011, Pages 1570-1581

  Sgolastra, Fabrizio ^a   Petrucci, Ambra ^a   Gatto, Roberto ^a   Giannoni, Mario ^a   Monaco, Annalisa ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Doxycycline; Matrix metalloproteinases; Meta analysis; Root planing

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE;

ANTIBIOTIC PROPHYLAXIS; DOSE RESPONSE; HUMAN; META ANALYSIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PERIODONTITIS; PREVENTIVE DENTISTRY; REVIEW; TIME;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; COMBINED MODALITY THERAPY; DENTAL PROPHYLAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PERIODONTITIS; TIME FACTORS;

EID: 80655129361     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2011.110026     Document Type: Review

References (91)

1. Salvi GE, Lang NP. Host response modulation in the management of periodontal diseases. J Clin Periodontol 2005;32(Suppl. 6):108-129. (Pubitemid 41391060)
2. Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol 1996;1:821-878.
3. Bartold PM, Narayanan AS. Molecular and cell biology of healthy and diseased periodontal tissues. Periodontol 2000 2006;40:29-49. (Pubitemid 43434240)
4. Greenstein G, Lamster I. Efficacy of subantimicrobial dosing with doxycycline. Point/counterpoint. J Am Dent Assoc 2001;132:457-466. (Pubitemid 33609915)
5. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: Summary of developments, clinical implications and future directions. Periodontol 2000 1997;14: 216-248. (Pubitemid 127601178)
6. Golub LM, Sorsa T, Lee HM, et al. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 1995;22:100-109.
7. Golub LM, Suomalainen K, Sorsa T. Host modulation with tetracyclines and their chemically modified analogues. Curr Opin Dent 1992;2:80-90.
8. Bhatavadekar NB, Williams RC. New directions in host modulation for the management of periodontal disease. J Clin Periodontol 2009;36:124-126.
9. Preshaw PM, Hefti AF, Bradshaw MH. Adjunctive subantimicrobial dose doxycycline in smokers and non-smokers with chronic periodontitis. J Clin Periodontol 2005;32:610-616. (Pubitemid 40780228)
10. Lee HM, Ciancio SG, Tüter G, Ryan ME, Komaroff E, Golub LM. Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug. J Periodontol 2004;75:453-463. (Pubitemid 38461128)
11. Ciancio SG. Systemic medications: Clinical significance in periodontics. J Clin Periodontol 2002;29(Suppl. 2): 17-21. (Pubitemid 41697790)
12. Kunchur R, Goss AN. The oral health status of patients on oral bisphosphonates for osteoporosis. Aust Dent J 2008;53:354-357, quiz 366.
13. Barragan-Adjemian C, Lausten L, Ang DB, Johnson M, Katz J, Bonewald LF. Bisphosphonate-related osteonecrosis of the jaw: Model and diagnosis with cone beam computerized tomography. Cells Tissues Organs 2009;189:284-288.
14. Walker C, Thomas J, Nangó S, Lennon J, Wetzel J, Powala C. Long-term treatment with subantimicrobial dose doxycycline exerts no antibacterial effect on the subgingival microflora associated with adult periodontitis. J Periodontol 2000;71:1465-1471.
15. Emingil G, Atilla G, Sorsa T, Tervahartiala T. The effect of adjunctive subantimicrobial dose doxycycline therapy on GCF EMMPRIN levels in chronic periodontitis. J Periodontol 2008;79:469-476.
16. Choi DH, Moon IS, Choi BK, et al. Effects of subantimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis. J Periodontal Res 2004;39:20-26.
17. Haffajee AD, Torresyap G, Socransky SS. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. J Clin Periodontol 2007;34:243-253.
18. Needleman I, Suvan J, Gilthorpe MS, et al. A randomized-controlled trial of low-dose doxycycline for periodontitis in smokers. J Clin Periodontol 2007;34: 325-333.
19. Tüter G, Serdar M, Kurtisx B, et al. Effects of scaling and root planing and subantimicrobial dose doxycycline on gingival crevicular fluid levels of matrix metalloproteinase-8, -13 and serum levels of HsCRP in patients with chronic periodontitis. J Periodontol 2010;81:1132-1139.
20. Tüter G, Kurtisx B, Serdar M, et al. Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease. J Clin Periodontol 2007;34:673-681.
21. Caton JG, Ciancio SG, Blieden TM, et al. Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol 2000;71:521-532. (Pubitemid 30602323)
22. Preshaw PM, Hefti AF, Novak MJ, et al. Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: A multicenter trial. J Periodontol 2004;75:1068-1076. (Pubitemid 39276489)
23. Lee JY, Lee YM, Shin SY, et al. Effect of subantimicrobial dose doxycycline as an effective adjunct to scaling and root planing. J Periodontol 2004;75:1500-1508.
24. Mohammad AR, Preshaw PM, Bradshaw MH, Hefti AF, Powala CV, Romanowicz M. Adjunctive subantimicrobial dose doxycycline in the management of institutionalised geriatric patients with chronic periodontitis. Gerodontology 2005;22:37-43.
25. Thomas JG, Metheny RJ, Karakiozis JM, Wetzel JM, Crout RJ. Long-term sub-antimicrobial doxycycline (Periostat) as adjunctive management in adult periodontitis: Effects on subgingival bacterial population dynamics. Adv Dent Res 1998;12:32-39.
26. Thomas J, Walker C, Bradshaw M. Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility. J Periodontol 2000;71:1472-1483.
27. Ciancio S, Ashley R. Safety and efficacy of subantimicrobial-dose doxycycline therapy in patients with adult periodontitis. Adv Dent Res 1998;12: 27-31.
28. Haffajee AD, Patel M, Socransky SS. Microbiological changes associated with four different periodontal therapies for the treatment of chronic periodontitis. Oral Microbiol Immunol 2008;23:148-157. (Pubitemid 351248610)
29. Reddy MS, Geurs NC, Gunsolley JC. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. Ann Periodontol 2003;8:12-37.
30. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of metaanalyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Metaanalyses. Lancet 1999;354:1896-1900.
31. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions, version 5.0.2 September 2009. Available at: http://www.cochrane- handbook.org. Accessed December 2, 2010.
32. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977; 33:363-374. (Pubitemid 8131514)
33. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33: 159-174. (Pubitemid 8054849)
34. Moher D, Schulz KF, Altman DG; CONSORT GROUP (Consolidated Standards of Reporting Trials). The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001;134:657-662. (Pubitemid 32322244)
35. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127: 820-826. (Pubitemid 27465551)
36. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558. (Pubitemid 34746062)
37. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. J Clin Epidemiol 2001;54:1046-1055. (Pubitemid 32888370)
38. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634. (Pubitemid 27387172)
39. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455-463. (Pubitemid 30422636)
40. Preshaw PM, Hefti AF, Jepsen S, Etienne D, Walker C, Bradshaw MH. Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. A review. J Clin Periodontol 2004;31:697-707. (Pubitemid 39186422)
41. Novak MJ, Dawson DR 3rd, Magnusson I, et al. Combining host modulation and topical antimicrobial therapy in the management of moderate to severe periodontitis: A randomized multicenter trial. J Periodontol 2008;79:33-41.
42. Kurtis B, Tüter G, Serdar M, Pinar S, Demirel I, Toyman U. GCF MMP-8 levels in smokers and non-smokers with chronic periodontitis following scaling and root planing accompanied by systemic use of flurbiprofen. J Periodontol 2007;78:1954-1961.
43. Kol R, Palattella A. The use of doxycycline in periodontology. Histologic in vivo study on mice affected by diabetes mellitus. Minerva Stomatol 2006;55:77-86.
44. Sorsa T, Tjäderhane L, Konttinen YT, et al. Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38:306-321. (Pubitemid 44385100)
45. Akalin FA, Baltacioǧlu E, Sengün D, et al. A comparative evaluation of the clinical effects of systemic and local doxycycline in the treatment of chronic periodontitis. J Oral Sci 2004;46:25-35.
46. Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 2003;8:115-181.
47. Herrera D, Sanz M, Jepsen S, Needleman I, Roldán S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 2002; 29(Suppl. 3):136-159; discussion 160-162. (Pubitemid 41719448)
48. Salvi GE, Mombelli A, Mayfield L, et al. Local antimicrobial therapy after initial periodontal treatment. J Clin Periodontol 2002;29:540-550.
49. Sigusch B, Beier M, Klinger G, Pfister W, Glockmann E. A 2-step non-surgical procedure and systemic antibiotics in the treatment of rapidly progressive periodontitis. J Periodontol 2001;72:275-283. (Pubitemid 32524491)
50. Alptekin NO, Kurtoglu F, Serpek B, Duran I, Gözlü M. Effects on the clinical indices and gingival crevicular fluid enzyme activities of the cyclical regimen of low-dose doxycycline therapy for adult periodontitis. J Int Acad Periodontol 2000;2:3-8.
51. Caton JG. Evaluation of Periostat for patient management. Compend Contin Educ Dent 1999;20:451-456, 458-460, 462, quiz 463.
52. Ashley RA; SDD Clinical Research Team. Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease. Ann N Y Acad Sci 1999;878:335-346. (Pubitemid 29353579)
53. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 1998;12:12-26.
54. Ng VW, Bissada NF. Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis. J Periodontol 1998;69:772-776. (Pubitemid 28363454)
55. Stoller NH, Johnson LR, Trapnell S, Harrold CQ, Garrett S. The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum. J Periodontol 1998;69:1085-1091. (Pubitemid 28487237)
56. Aitken S, Birek P, Kulkarni GV, Lee WL, McCulloch CA. Serial doxycycline and metronidazole in prevention of recurrent periodontitis in high-risk patients. J Periodontol 1992;63:87-92.
57. Kulkarni GV, Lee WK, Aitken S, Birek P, McCulloch CA. A randomized, placebo-controlled trial of doxycycline: Effect on the microflora of recurrent periodontitis lesions in high risk patients. J Periodontol 1991;62:197-202.
58. Golub LM, Ciancio S, Ramamamurthy NS, Leung M, McNamara TF. Low-dose doxycycline therapy: Effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res 1990;25:321-330.
59. Asikainen S, Jousimies-Somer H, Kanervo A, Saxén L. The immediate efficacy of adjunctive doxycycline in treatment of localized juvenile periodontitis. Arch Oral Biol 1990;35(Suppl.):231S-234S.
60. Saxén L, Asikainen S, Kanervo A, Kari K, Jousimies-Somer H. The long-term efficacy of systemic doxycy-cline medication in the treatment of localized juvenile periodontitis. Arch Oral Biol 1990;35(Suppl.):227S-229S.
61. Preshaw PM, Novak MJ, Mellonig J, et al. Modified-release subantimicrobial dose doxycycline enhances scaling and root planing in subjects with periodontal disease. J Periodontol 2008;79:440-452.
62. Deo V, Gupta S, Bhongade ML, Jaiswal R. Evaluation of subantimicrobial dose doxycycline as an adjunct to scaling and root planing in chronic periodontitis patients with diabetes: A randomized, placebo-controlled clinical trial. J Contemp Dent Pract 2010; 11:009-016.
63. Payne JB, Stoner JA, Nummikoski PV, et al. Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women. J Clin Periodontol 2007;34:776-787.
64. Reinhardt RA, Stoner JA, Golub LM, et al. Efficacy of sub-antimicrobial dose doxycycline in post-menopausal women: Clinical outcomes. J Clin Periodontol 2007;34:768-775(erratum 2007;34:1097).
65. Górska R, Nedzi-Góra M. The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis. Arch Immunol Ther Exp (Warsz) 2006;54:419-426. (Pubitemid 44968895)
66. Gürkan A, Cinarcik S, Hüseyinov A. Adjunctive sub-antimicrobial dose doxycycline: Effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis. J Clin Periodontol 2005;32:244-253. (Pubitemid 40462656)
67. Llambés F, Silvestre FJ, Hernández-Mijares A, Guiha R, Caffesse R. Effect of non-surgical periodontal treatment with or without doxycycline on the periodontium of type 1 diabetic patients. J Clin Periodontol 2005;32:915-920. (Pubitemid 41008332)
68. Caton JG, Ciancio SG, Blieden TM, et al. Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: Post-treatment effects. J Clin Periodontol 2001;28:782-789. (Pubitemid 33761320)
69. Golub LM, McNamara TF, Ryan ME, et al. Adjunctive treatment with subantimicrobial doses of doxycycline: Effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001;28:146-156. (Pubitemid 33761359)
70. Emingil G, Gürkan A, Atilla G, Kantarci A. Subantimicrobial-dose doxycycline and cytokine/chemokine levels in gingival crevicular fluid [Epub ahead of print]. J Periodontol 2011;82:452-461.
71. Emingil G, Atilla G, Sorsa T, Luoto H, Kirilmaz L, Baylas H. The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis. J Periodontol 2004;75:106-115. (Pubitemid 38312775)
72. Emingil G, Gürkan A, Atilla G, Berdeli A, Cinarcik S. Adjunctive low-dose doxycycline therapy effect on clinical parameters and gingival crevicular fluid tissue plasminogen activator levels in chronic periodontitis. Inflamm Res 2006;55:550-558. (Pubitemid 46130064)
73. Gürkan A, Emingil G, Cinarcik S, Berdeli A. Posttreatment effects of subantimicrobial dose doxycycline on clinical parameters and gingival crevicular fluid transforming growth factor-beta1 in severe, generalized chronic periodontitis. Int J Dent Hyg 2008;6:84-92.
74. Turesky S, Gilmore ND, Glickman I. Reduced plaque formation by the chloromethyl analogue of victamine C. J Periodontol 1970;41:41-43.
75. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21: 533-551.
76. Quigley GA, Hein JW. Comparative cleansing efficiency of manual and power brushing. J Am Dent Assoc 1962;65:26-29.
77. Saxer UP, Mühlemann HR. Motivation and education (in German). SSO Schweiz Monatsschr Zahnheilkd 1975;85:905-919.
78. Van Dyke TE. The clinical significance of new therapies for the management of periodontal disease. J Int Acad Periodontol 2005;7(Suppl. 4):191-196.
79. Golub LM, Lee HM, Greenwald RA, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 1997;46:310-319. (Pubitemid 27399588)
80. Heasman PA, Vernazza CR, Gaunt FL, Pennington MW. Cost-effectiveness of adjunctive antimicrobials in the treatment of periodontitis. Periodontol 2000 2011;55:217-230.
81. Guentsch A, Kramesberger M, Sroka A, Pfister W, Potempa J, Eick S. Comparison of gingival crevicular fluid sampling methods in patients with severe chronic periodontitis. J Periodontol 2011;82:1051-1060.
82. Löe H, Holm-Pedersen P. Absence and presence of fluid from normal and inflamed gingivae. Periodontics 1965;149:171-177.
83. Oliver RC, Holm-Pederen P, Löe H. The correlation between clinical scoring, exudate measurements and microscopic evaluation of inflammation in the gingiva. J Periodontol 1969;40:201-209.
84. Hanemaaijer R, Visser H, Van den Hoogen CM, Sorsa T, Van Hinsbergh VW. Inhibition of urokinase-type and tissue-type plasminogen activator-mediated plasminogen activation by doxycycline. Fibrinolysis 1996; 10:109-111. (Pubitemid 26344808)
85. Buduneli N, Kinane DF. Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. J Clin Periodontol 2011; 38(Suppl. 11):85-105.
86. Loos BG, Tjoa S. Host-derived diagnostic markers for periodontitis: Do they exist in gingival crevice fluid? Periodontol 2000 2005;39:53-72. (Pubitemid 43026179)
87. Salvi GE, Lawrence HP, Offenbacher S, Beck JD. Influence of risk factors on the pathogenesis of periodontitis. Periodontol 2000 1997;14:173-201. (Pubitemid 127601176)
88. Ah MK, Johnson GK, Kaldahl WB, Patil KD, Kalkwarf KL. The effect of smoking on the response to periodontal therapy. J Clin Periodontol 1994;21:91-97.
89. McGuire MK, Nunn ME. Prognosis versus actual outcome. III. The effectiveness of clinical parameters in accurately predicting tooth survival. J Periodontol 1996; 67:666-674. (Pubitemid 126613045)
90. Mäntylä P, Stenman M, Kinane D, et al. Monitoring periodontal disease status in smokers and non-smokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test. J Periodontal Res 2006;41:503-512. (Pubitemid 44656925)
91. Liede KE, Haukka JK, Hietanen JH, Mattila MH, Rönkä H, Sorsa T. The association between smoking cessation and periodontal status and salivary proteinase levels. J Periodontol 1999;70:1361-1368.